Education

  • Columbia Law School (J.D., 2013) Harlan Fiske Stone Scholar
  • University of Michigan (B.S., Biochemistry, 2008)

Andrew Krause is a litigation associate in the Los Angeles office of Irell & Manella LLP, where he is a member of the firm's litigation and IP litigation practice groups. He is registered to practice before the United States Patent and Trademark Office.

Mr. Krause has represented clients from a variety of industries in district courts, in the Patent Office, and before the International Trade Commission. Representative life sciences clients for whom Mr. Krause has worked include Genentech, Gilead Sciences, and Rigel Pharmaceuticals. Representative technology clients include Juniper Networks and Skyworks Solutions.

Mr. Krause received his J.D. from Columbia Law School, where he was a Harlan Fiske Stone Scholar, and his B.S. from the University of Michigan. From 2008 to 2010, he worked as a Patent Examiner at the United States Patent and Trademark Office. 

Read More

Representative Matters

  • Celltrion v. Genentech; Pfizer v. Genentech; and Sandoz v. Genentech (PTAB): Mr. Krause is currently defending Genentech in connection with numerous IPR petitions for multiple patents relating to methods of using Genentech’s blockbuster drug, rituximab. The petitioners are competitors who have filed, or plan to file, for regulatory approval to market biosimilar versions of rituximab under the Biologics Price Competition and Innovation Act.
  • In re Mobile Telecommunications Technologies, LLC (E.D. Tex. / D. Del. / MDL): Mr. Krause is representing Juniper Networks in a multi-district patent litigation in which the plaintiff asserted a number of patents relating to wireless communications technologies. Following a favorable claim construction ruling, the plaintiff dismissed all claims with respect to one of the asserted patents, and stipulated to non-infringement of the others. The case is currently pending appeal.
  • Mr. Krause represented a small, innovative, pharmaceutical company in a complex patent infringement suit concerning an FDA-approved small-molecule cancer drug. The case settled favorably.
  • Mr. Krause represented the technology transfer office of a major research university in an investigation relating to the improper use of research funding and misappropriation of intellectual property by a former graduate student.
View More
View More
View More
View More
View More
View More

Bar & Court Admissions

  • 2013, California
  • U.S. District Court, Northern District of California
  • U.S. Patent and Trademark Office